Pharmacovigilance

Vigilance is our key for patient safety. Patient safety is our primary and main objective!

Statistics & Data Analysis

We choose the right statistical tool and computational model to analyse your data.

Clinical Operations

We streamline clinical operations to provide efficacious solutions for complex projects.

Medical Consulting

Exceptional medical consultations to pharmaceutical and medical device companies!

Medical Writing

Our state of the art medical writing deliverables stand out!

Research & Development

We support drug development pipelines from benchside to "market"side.

Quality Assurance

Top-notch services are our goal. Quality is the essence of success.

Don't Delay!

Don't delay any longer. Schedule your consultation with our team today!

Blogs and Industry News for Pharmacovigilance & Clinical Operations

5-minute weekly newscast – 26/05/2019

By MD Pharma Consulting Group | May 26, 2019

The spotlight is on President Donald Trump who will sign an executive order within the next few days authorizing disclosure of costs across the healthcare industry including drug prices. Big Data and advanced data analytics are revolutionizing the industry. Circuit Clinical, an American based patient-oriented integrated research organization, announced partnership…

Recent Advances in Treatment of Stage IV Metastatic Breast Cancer

By MD Pharma Consulting Group | May 19, 2019

Breast cancer is the most common cancer type in women worldwide. It is estimated that 70% of patients with breast cancer are estrogen receptor (ER)-positive, making hormonal therapies using ER antagonists and degraders, such as tamoxifen and fulvestrant, common treatments for breast cancer. However, therapies with ER-independent mechanisms are needed…

5-minute weekly newscast – 19/05/2019

By MD Pharma Consulting Group | May 19, 2019

The spotlight is on Gilead, a market leader in HIV treatment, who shared the promising news of donating 2.4 million bottles of Truvada to help ending the HIV epidemic in the United States. Astra Zeneca is implementing artificial intelligence and machine learning for the discovery and development of new treatments for chronic…

Recent Advances in Treatment of Stage IV Metastatic Non-Small Cell Lung Cancer

By MD Pharma Consulting Group | April 19, 2019

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Approximately 40% of NSCLC patients are diagnosed with stage IV after the tumor has metastasized. As NSCLC is less sensitive to chemotherapy compared to small cell lung cancer (SCLC), research focus has focused on the development of…

Choosing the Right Immunoassays for Your Radiobiology Experiments

By MD Pharma Consulting Group | March 21, 2019

Radiation therapy is one of the most common treatments for cancer. In order to improve the treatment efficacy of radiation therapies, radiobiology is the field of basic research that studies the cellular and molecular biological factors influencing the response of cancerous and normal cell lines to ionizing radiation. In a…

Causality Assessment Methods of Hepatic Adverse Drug Reactions: Opportunities for Enhancement

By MD Pharma Consulting Group | November 1, 2018

Joint Event on International Conference on WORLD DRUG DELIVERY AND NOVEL THERAPY SUMMIT & Annual Congress on NEUROSCIENCE & THERAPEUTICS October 25-26, 2018 | Toronto, Canada Conference Date: October 25-26, 2018 Conference Venue: Hotel Park Inn By Radisson Toronto Airport West Address: 175 Derry Rd E, Mississauga, ON L5T 2Z7,…

MD Pharma College (Coming Soon)

By MD Pharma Consulting Group | April 16, 2018

Ever since its’ foundation, MD Pharma College has adopted a vision that prepares our STEM graduates to be industry-ready. As a STEM graduate considering a private postsecondary institution to expand your knowledge base on healthcare sciences, you will strongly consider MD Pharma College for the following reasons: MD Pharma College…

Why MD Pharma Consulting Group?

By MD Pharma Consulting Group | April 15, 2018

MD Pharma consulting group is a science driven quality focused contract research organization (CRO) that provides innovative consultations and executive solutions to diverse bio-pharmaceutical and medical device industry stakeholders. MD Pharma Consulting Group is a resourceful CRO that employs its’ strategic capabilities towards supporting the development of drugs and medical…

Welcome to MD Pharma Consulting Group

By MD Pharma Consulting Group | April 14, 2018

Q: Tell us about yourself A: MD Pharma Consulting Group is a contract research organization (CRO) that provides consultations, plans, and operations to diverse bio-pharmaceutical and medical device industry stakeholders. Q: What is a contract research organization? A: A contract research organization (CRO) is a vendor that provides support to…